Xbrane Biopharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2019-03-22 | Xbrane Biopharma AB | Paolo Sarmientos | Member of the Management Team | Disposal | 1 272 295 | 0,287 | SEK | 365 148,665 | 2019-03-17 |
| 2019-03-22 | Xbrane Biopharma AB | Paolo Sarmientos | Member of the Management Team | Disposal | 803 | 0,27 | SEK | 216,81 | 2019-03-18 |
| 2019-03-22 | Xbrane Biopharma AB | Paolo Sarmientos | Member of the Management Team | Disposal | 12 528 | 0,415 | SEK | 5 199,12 | 2019-03-17 |
| 2019-03-25 | Xbrane Biopharma AB | Anders Tullgren | styrelseordf | Subscription | 10 267 | 30 | SEK | 308 010 | 2019-03-24 |
| 2019-03-25 | Xbrane Biopharma AB | Saeid Esmaeilzadeh | Styrelseledamot/suppleant | Disposal | 143 795 | 0,26 | SEK | 37 386,7 | 2019-03-24 |
| 2019-03-26 | Xbrane Biopharma AB | Paolo Sarmientos | Member of the Management Team | Disposal | 693 969 | 0,248 | SEK | 172 104,312 | 2019-03-20 |
| 2019-03-26 | Xbrane Biopharma AB | Saeid Esmaeilzadeh | Styrelseledamot/suppleant | Subscription | 213 540 | 30 | SEK | 6 406 200 | 2019-03-21 |
| 2019-03-26 | Xbrane Biopharma AB | Siavash Bashiri | COO & Head of Biosimilar/Vice VD | Subscription | 2 134 | 30 | SEK | 64 020 | 2019-03-24 |
| 2019-03-26 | Xbrane Biopharma AB | Giorgio Chirivi | Board Member | Acquisition | 30 000 | 0,046 | EUR | 1 377 | 2019-03-18 |
| 2019-03-27 | Xbrane Biopharma AB | Susanna Helgesen | Ekonomi/finanschef | Subscription | 4 279 | 30 | SEK | 128 370 | 2019-03-20 |
| 2019-03-27 | Xbrane Biopharma AB | Susanna Helgesen | Ekonomi/finanschef | Acquisition | 68 464 | 0,258 | SEK | 17 663,712 | 2019-03-20 |
| 2019-03-27 | Xbrane Biopharma AB | Susanna Helgesen | CFO | Subscription | 1 361 | 30 | SEK | 40 830 | 2019-03-17 |
| 2019-03-27 | Xbrane Biopharma AB | Alessandro Sidoli | Board Member | Disposal | 384 425 | 0,249 | SEK | 95 614,186 | 2019-03-24 |
| 2019-03-27 | Xbrane Biopharma AB | Karl Martin Erik Åmark | VD | Subscription | 13 800 | 30 | SEK | 414 000 | 2019-03-26 |
| 2019-03-27 | Xbrane Biopharma AB | Karl Martin Erik Åmark | VD | Subscription | 3 704 | 30 | SEK | 111 120 | 2019-03-24 |
| 2019-03-27 | Xbrane Biopharma AB | David Vikström | Forskningschef | Subscription | 1 333 | 30 | SEK | 39 990 | 2019-03-24 |
| 2019-03-29 | Xbrane Biopharma AB | Siavash Bashiri | COO & Head of Biosimilars/Vice VD | Allotment | 8 706 | 30 | SEK | 261 180 | 2019-03-28 |
| 2019-04-01 | Xbrane Biopharma AB | Anders Tullgren | styrelseordf | Acquisition | 2 571 | 30 | SEK | 77 130 | 2019-03-28 |
| 2019-04-01 | Xbrane Biopharma AB | David Vikström | Forskningschef | Acquisition | 3 160 | 30 | SEK | 94 800 | 2019-03-28 |
| 2019-04-02 | Xbrane Biopharma AB | Maris Hartmanis | Styrelseledamot/suppleant | Acquisition | 157 | 30 | SEK | 4 710 | 2019-04-01 |